Literature DB >> 24850755

Interaction of TIF-90 and filamin A in the regulation of rRNA synthesis in leukemic cells.

Le Xuan Truong Nguyen1, Steven M Chan2, Tri Duc Ngo3, Aparna Raval1, Kyeong Kyu Kim3, Ravindra Majeti2, Beverly S Mitchell1.   

Abstract

The transcription initiation factor I (TIF-IA) is an important regulator of the synthesis of ribosomal RNA (rRNA) through its facilitation of the recruitment of RNA polymerase I (Pol I) to the ribosomal DNA promoter. Activation of the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway, which occurs commonly in acute myelogenous leukemia, enhances rRNA synthesis through TIF-IA stabilization and phosphorylation. We have discovered that TIF-IA coexists with a splicing isoform, TIF-90, which is expressed preferentially in the nucleolus and at higher levels in proliferating and transformed hematopoietic cells. TIF-90 interacts directly with Pol I to increase rRNA synthesis as a consequence of Akt activation. Furthermore, TIF-90 binds preferentially to a 90-kDa cleavage product of the actin binding protein filamin A (FLNA) that inhibits rRNA synthesis. Increased expression of TIF-90 overcomes the inhibitory effect of this cleavage product and stimulates rRNA synthesis. Because activated Akt also reduces FLNA cleavage, these results indicate that activated Akt and TIF-90 function in parallel to increase rRNA synthesis and, as a consequence, cell proliferation in leukemic cells. These results provide evidence that the direct targeting of Akt would be an effective therapy in acute leukemias in which Akt is activated.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24850755     DOI: 10.1182/blood-2013-12-544726

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome.

Authors:  Arun K Nalla; Theodore F Williams; Casey P Collins; Dustin T Rae; Grant D Trobridge
Journal:  Mol Carcinog       Date:  2015-10-29       Impact factor: 4.784

2.  TIF-90 tips the balance in rRNA synthesis.

Authors:  Katherine L B Borden
Journal:  Blood       Date:  2014-07-24       Impact factor: 22.113

Review 3.  TIF-IA: An oncogenic target of pre-ribosomal RNA synthesis.

Authors:  Rui Jin; Wei Zhou
Journal:  Biochim Biophys Acta       Date:  2016-09-15

4.  Proteome analysis of sheep B lymphocytes in the course of bovine leukemia virus-induced leukemia.

Authors:  Michal Reichert
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-24

5.  Cytoskeletal Filamin A Differentially Modulates RNA Polymerase III Gene Transcription in Transformed Cell Lines.

Authors:  Juan Wang; Shasha Zhao; Yun Wei; Ying Zhou; Paul Shore; Wensheng Deng
Journal:  J Biol Chem       Date:  2016-10-13       Impact factor: 5.157

6.  Synergy of Venetoclax and 8-Chloro-Adenosine in AML: The Interplay of rRNA Inhibition and Fatty Acid Metabolism.

Authors:  Dinh Hoa Hoang; Corey Morales; Ivan Rodriguez Rodriguez; Melissa Valerio; Jiamin Guo; Min-Hsuan Chen; Xiwei Wu; David Horne; Varsha Gandhi; Lisa S Chen; Bin Zhang; Vinod Pullarkat; Steven T Rosen; Guido Marcucci; Ralf Buettner; Le Xuan Truong Nguyen
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.